Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 16,500 shares at $22.92 ($378K) on 2011-12-01, disclosed to the SEC on 2011-12-05.
Scheduled sale ($378k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |